Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV (Q79338429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Christoph Boss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Olivier Corminboeuf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Corinna Grisostomi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Solange Meyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Andrew F Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Lars Prade

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Christoph Binkert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Walter Fischli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Thomas Weller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Daniel Bur

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1341-1345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17091526%20AND%20SRC:MED&resulttype=core&format=json

The global distribution of clinical episodes of Plasmodium falciparum malaria

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Medical need, scientific opportunity and the drive for antimalarial drugs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

The pathway of hemoglobin degradation in malaria parasites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Genome sequence of the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

The role of Plasmodium falciparum food vacuole plasmepsins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Synthesis of Plasmepsin II Inhibitors – Potential Antimalarial Agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

X-ray structure of plasmepsin II complexed with a potent achiral inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Pi-pi interactions: the geometry and energetics of phenylalanine-phenylalanine interactions in proteins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

The Cambridge Structural Database: a quarter of a million crystal structures and rising

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Extracting hydrophobic free energies from experimental data: relationship to protein folding and theoretical models

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Structural insights into the activation of P. vivax plasmepsin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021

Starving the malaria parasite: inhibitors active against the aspartic proteases plasmepsins I, II, and IV.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600223

7 January 2021